Uzbekistan

in page functions
[French]
Uzbekistan
Total population (2017) 30,689,167
Birth cohort (2017) 650,564
Surviving Infants (surviving to 1 year per year, 2017) 623,818
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 34/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 39/1000
World Bank Index, IDA (2015) 3.43
Gross Nation Income (per capita US$, 2015) 2,160
Co-financing group (2017) Accelerated transition
No. of districts/territories (2015) 196

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Uzbekistan

Type of support

Approvals

2001-2021 (US$)
(20 Dec 2016)

Commitments

2001-2021 (US$)
(20 Dec 2016)

Disbursements

2000-2016 (US$)
(20 Dec 2016)

% Disbursed

(20 Dec 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $72,532,283 $90,171,262 $67,928,985
Graduation grant (GG) $227,910 $227,910 $227,910 100%
Health system strengthening (HSS 1) $7,380,000 $17,218,480 $3,837,201 52%
HepB mono (NVS) $4,358,659 $4,358,659 $4,358,659 100%
HPV (NVS) N/A
Immunisation services support (ISS) N/A
Injection Safety Devices (NVS) $126,000 $227,500
Injection safety support (INS) $727,012 $727,012 $727,012 100%
IPV (NVS) $3,120,695 $3,120,695 $83,279 3%
Penta (NVS) $31,928,057 $32,409,557 $32,022,057 100%
Pneumo (NVS) $15,174,665 $21,747,165 $17,793,079 117%
Rotavirus (NVS) $7,135,785 $7,780,785 $7,087,288 99%
Vaccine Introduction Grant (VIG) $2,353,500 $2,353,500 $1,792,500 76%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Uzbekistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 99%
M:F sex ratio at birth (2017) 1.06
Household survey: DTP3 coverage for male (2005) 93.50%
Household survey: DTP3 coverage for female (2005) 92.80%
Household survey: Last DTP3 survey (2005) 93%
% districts achieving > 80% DTP3 coverage (2015) 100%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2015) 99%

Breakdown of support

Non-vaccine support Vaccine support
10% 90%
$6,584,622 $61,344,359

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Uzbekistan

11 November 2016

Feature 2 Nepal BG

Fighting pneumonia in Nepal: making numbers count

At Kathmandu’s Patan hospital, Gavi is funding impact studies on two vaccines that protect children against the main causes of deadly pneumonia: Haemophilus influenzae type b (Hib) and pneumococcal disease. Three doctors who are leading these studies identify four ways in which Patan’s pioneering research is shaping Nepal’s immunisation policy.

08 March 2014

GAVI HPV vaccine infographic 2014 3x2

1.5 million girls set to benefit from vaccine against cervical cancer

GAVI Alliance support for national introductions marks new HPV vaccine milestone on International Women’s Day.

05 October 2012

Tanzania rotavirus rollout Sister Moshi

Useful information

Useful information for anyone attending the Partners' Forum in Tanzania: Climate, Passports & Visas, Health, Safety, General behaviour in public, Currency, Tipping, Electricity, Shopping

close icon

modal window here